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Longitudinal follow—up of chronic hemodialysis patients without vita-
min supplementation. Vitamin supplementation for dialysis patients is
still controversial. In our study, we followed longitudinally over a
period of a year, 15 patients on chronic hemodialysis who were
deprived of vitamin supplementation. Microbiological assays were used
to determine the levels of five vitamins of the B group (folate, niacin,
B12, B, and thiamine). Vitamin C was measured chemically. During the
observation period when vitamins were not supplemented, a marked
drop of many of these vitamins in blood levels were encountered. For
vitamins B12 and C, the plasma levels remained within the normal range
in all the subjects studied. For the other vitamins, the blood levels were
found to be low in a few patients. Our data suggest that vitamin
supplementation is probably not needed in most stable hemodialysis
patients as it is recommended now, and that perhaps, if supplementa-
tion is indicated, less should be given than is presently prescribed.
Further research is needed in this area.
The need for vitamin supplementation in hemodialysis pa-
tients, as well as the quantity and amount of supplementation,
remains controversial. Of the water soluble vitamins, vitamin
B12 is not appreciably dialyzed, and the serum levels in dialysis
patients have been reported as normal or elevated [1—3]. Folate
levels have been found to be low normal or normal [3—61.
Pyridoxine has been reported as low [7] or normal $1, although
in this latter study the patients received vitamin supplementa-
tion. Thiamine has been found to be normal [91 and other
vitamins such as niacin, pantothenic acid and biotin have been
reported to be of normal concentrations in heniodialyzed pa-
tients [10, 111.
Because of the controversy, we decided to study longitudi-
nally the effect of no vitamin supplementation on vitamin B12,
B6, folate, thiamine and vitamin C levels in plasma, as well as
folate, thiamine and niacin levels in red cells. We studied fifteen
patients on long-term hemodialysis and reported the results of
12 months of observation.
Methods
Fifteen clinically stable, non-diabetic patients (fourteen
males and one female) who participated in this study were
maintained on hemodialysis at the Tampa VA Medical Center.
All of the patients had intact native kidneys. Their mean age
was 58 11 years (mean SD) (range 32 to 73 years), All of the
patients undergoing long—term hemodialysis at the time the
study began were taking the following medications: aluminum
hydroxide (phosphate binder), ferrous sulfate, 324 mg three
times per day, antihypertensive medications whenever indi-
cated, Albee with C vitamink, (one 200 mg tablet per day, 15 mg
of thiamine, 10.2 nig of riboflavin, 50 mg of niacin, 5 mg of
vitamin B6, 10 mg of pantothenic acid) and I tablet of folic acid
(I mg) per day. None of the patients were severely protein—
restricted. Their dietary prescription was based on 1 g of
protein per kg of ideal body wt in accordance with the 1983
Metropolitan Life Insurance tables, Therefore, the patients
were following diets roughly from 60 to 80 g per day. Table 1
shows the average vitamin B and C content of the suggested
diet. All of the patients received sodium heparin as the
anticoagulant. All of the patients were dialyzed on a Gambro
AK-b machine using a parallel plate dialyzer (1.2 m 2 Gambro,
Barrington, Illinois, USA) four hr per treatment, three times a
week. The patients included in the study were on chronic
maintenance hemodialysis for an average time of 16.5 6
months (mean SD) (range 4 to 38 months). After a full
explanation of the study, the patients consented to stop taking
the Albee with C vitamins and the folic acid. The pharmacy was
notified as well that these two medications should not be
supplied again to the patients.
Collection of blood samples
Blood samples were obtained at the beginning of the study for
baseline values. Then, samples were obtained every month for
six months, and then every other month for the next six
months. Hematocrit was determined in each sample using a
Drummond Microhematocrit (The Drummond Scientific Co.,
Broomall, Pennsylvania, USA). At all times the blood samples
were protected from the light. Aliquots of whole blood and
plasma were stored at —70°C until analyzed.
Vitamin standards
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Cyanocobalamin, thiamine HCL, niacin, pyridoxal phos-
phate and dI-N-5-methyltetrahydrofolate were purchased com-
mercially (USP Reference Standards, Rockville, Maryland, and
Sigma Chemical Company, St. Louis, Missouri, USA). The
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Table 1. Content of B and C vitamins of the diet.
70 gm Protein,
2 gin Na 3 gm K
FOODS
Vitamin C
mg
Thiamine
ing
Riboflavin
mg
Niacin
mg
Pyridoxine
B6 mg
Folacin
p.g
8 oz. Milk 2 0.1 0.5 0.25 0.096 12
1 Egg 0 0.1 0.1 0.1 0.05 29
6 oz. Meat 0 0.34 0.25 10.9 0.9 12
7 Starches/Breads 10 0.73 0.1 6.0 0.23 80
3 Vegetables 100 0.15 0.1 1.0 0.18 70
3 Fruits 100 0.33 0 0.8 0.23 50
Lemonade/Kool aid 50 0.02 0 0.5 0.03 20
Fats 0 0 0 0 0 0.5
Totals 262 1.77 1.05 19.5 1.7 273
RDA for Males 60 1.2 1.4 16 2.2 400
RDA for Females 60 1.0 1.2 13 2.0 400
stock solutions of these vitamins (except dl-N-5-methyl-
etetrahydrofolate) were prepared in deionized water and the
concentrations were checked spectrophotometrically before
use [12]. Aliquots of these solutions were stored at —70°C, Prior
to their use, the exact concentrations of the standard solutions
were determined spectrophotometrically from the molar extinc-
tion [121. On the days of the assays, the working standards
(corrected for the measured concentration) were prepared in
deionized water in the same buffer called for by the assay.
The sodium salt of dI-N-5-methyletetrahydrofolate was pre-
pared in 0.05 M phosphate buffer, pH 6.1. After the concentra-
tion was checked spectrophotometrically, ascorbic acid was
added to a final concentration of 0.2%. The working standard
was prepared in the fresh phosphate—ascorbate buffer after
correcting for the measured concentration and for the presence
of the (d) diastereoisomer, and the molar equivalents to
pteroylmonoglutamic acid.
Vitamin analyses
Microbiological assays were used in all of the vitamin deter-
minations. Plasma and red cell folate were determined using
lactobacillus casei as previously described [13]. A modification
of the method of Snell and Wright l4] was used for red cell
niacin determination. Blood samples were diluted one—to—one
with deionized water, then 0.2 N acetate buffer, pH 4.6 was
added to a final dilution of one—in—twenty. The samples were
autoclaved for ten mm, cooled and centrifuged. The resulting
supernates were used for niacin analysis. The amount of niacin
in the red cell was calculated based on the prior determination
of the sample hematocrit. Plasma pyridoxal levels were deter-
mined using Kloeckera brevis [iS, 161 with the following
modifications: the standard curve was prepared by adding
different volumes of pyridoxal—phosphate, ranging in concen-
tration from 0 to 8 ng per assay tube, in triplicate (16 x 150 mm,
Kimble, Toledo, Ohio, USA). One ml of acid phosphatase, type
II (Sigma Chemical Co.) (0.15 mg dissolved in 0.05 M citrate
buffer, pH 4.6) was added to each tube. The volume in each
tube was then raised to 2.5 ml with citrate buffer. Plasma
samples (0.5 ml) were diluted with citrate buffer, and I ml of
acid phosphatase (0.5 mg) was added to each sample, making
the total volume 5 ml. Enzyme blanks were included with each
experiment. The tubes were capped and incubated in a shaking
bath at 37°C for 3-1/2 to 4 hr. After incubation, 2.5 ml of
pyridoxine Y Medium (Difco Laboratories, Detroit, Michigan,
USA) was added to the tubes, which made up the standard
curve and the blank tubes. All the tubes were then loosely
capped and autoclaved for S mm at 121°, 15 p.s.i. After cooling,
the plasma samples were centrifuged and different volumes of
the supernates were aseptically transferred to tubes containing
citrate buffer and 2.5 ml Pyridoxal Y Medium (prepared and
autoclaved together with the plasma samples and standards).
The total volume per tube was 5 ml. One tenth milliliter of a one
to ten dilution of overnight growth of K brevis (washed three
times in a single concentration of the assay medium) was added
to each tube. The tubes were slanted at approximately a 15°
angle and incubated for 20 h at 30°C.
Plasma vitamin B12 levels were determined using Lactobacil-
lus leichmannii as described by Matthews [17]. Plasma and red
cell thiamine levels were measured using a modification of the
method of Hoff—Jorgensen and Hansen [181.
In all of the above microbiological assays, Difco's assay
media were used (Difco Laboratories). Growth of the test
organisms was measured at 640 nm using a spectrophotometer
(Bausch and Lomb Spectronics 20).
With each vitamin assay, a standard curve as well as two
control samples were included. For each sample for vitamin
analysis, a minimum of three dilutions were used. In this way,
errors due to nonspecific stimulation of inhibition could be
prevented. Recovery studies were also performed to validate
the assay values. Pyridoxine acid and thiamine analyses were
carried out under reduced light.
Vitamin C was also measured in the 15 patients in which
other vitamins were studied. Also, eight patients were added for
this specific vitamin study, making a total of 23 patients (mean
age 43 11 years, mean SD range 32 to 73 years). After the
blood was collected for the vitamin C assay, the tubes were
centrifuged at 10,000 G for 15 mill, and the plasma, carefully
removed, was deproteinized using 40% tricholoacetic acid. The
tubes were then spun at 15,000 G for 15 mm. The clear
supernate was used for the vitamin C assay according to the
method of Zannoni et al [19]. A standard ascorbic acid solution
of 5% TCA containing 1Ig/0.15 ml was carried through the
method. The calculated molar extinction coefficient of ascorbic
acid was 14,964. One microgram of ascorbic acid carried
through the procedure gave a density reading of 0.035. Normal
healthy controls for vitamin C consisted of two groups of
subjects who were not on vitamin C supplements. They were
young adult (34 years) and older (72 years) individuals. The
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normal range for the B vitamins were established from 33
healthy subjects, 20 to 60 years old, who were not on vitamin
supplements.
As a routine follow-up, monthly blood samples were drawn
from all of the patients in the study for hemoglobin, hematocrit,
platelet count, red blood cell indices, white cell count and
differential performed. SMAC-20 (Technicon SMAC, Ter-
rytown, New York, USA), iron, iron binding capacity and
transferrin serum determinations were also performed on a
monthly basis.
A careful dietary evaluation was done by one of the authors
at the beginning of the study and at monthly intervals during the
period of observations, but no efforts were made to change the
established dietary habits of the patients.
Results
Folate
The plasma and red blood cell folate levels are shown in
Figure 1. After discontinuing vitamin supplementation, a rapid
decline in red blood cell and plasma concentration follows. This
decrement seems to plateau at six months after the discontinua-
tion of the vitamin supplementation and then without supple-
mentation, the levels improved slightly and remained within the
normal limits for most patients. A few had blood folate levels
below the normal range.
Niacin
Figure 2 shows the levels of niacin in whole blood and red
blood cells. The levels for this vitamin in the whole blood are
borderline low normal and remained so during the entire time of
vitamin deprivation. The niacin concentration in the red blood
cells was normal in the majority of the patients and remained so
during the entire time. Furthermore, after the sixth nionth, the
mean concentration of niacin seems to increase to the upper
limit of normal. Niacin is mainly found in red cells or tissue and
not in plasma. The amount of red cells in our dialysis patients
was diminished because of their chronic anemia. The fact that
niacin levels in whole blood were low normal is, therefore, a
reflection of dilution and not actual niacin deficiency.
B12, B6, Thiamine
The plasma concentration of vitamin B12 and B6 are shown in
Figure 3. Although supplementation was never given to our
patients, not even before the study, Vitamin B12 levels re-
mained within normal limits. Vitamin B6 levels were normal for
most patients. One or two had levels below the normal range.
Figure 4 shows the results of the red cell and plasma concen-
tration of thiamine. After stopping the vitamin supplementa-
tion, a rapid decline in red cell and plasma thiamine concentra-
tion was observed. For most patients, the thiamine levels
remained within the normal limits, while a few had plasma and
red cell thiamine levels below the normal age.
Vitamin C
Figure 5 displays the levels of plasma vitamin C over 12
months after discontinuation of vitamin C. There was a rapid
decline of the blood levels of this vitamin in our patients, but the
levels then stabilized and remained within the normal limit for
the rest of the year in the majority of the patients.
2400
2200
2000
1800
16000
- 140000 1200
-D
n 1000
5)
800
, 600
400
200
0
45
• . .I:Ii) 6
3000 250
20
15
. 10
u 5
cc2 0
0 1 2 34 5 6 7 8 9101112
IS,
a,
cc
0
cc
E0)
cc
a-
40
35
30
25
20
15
10
5
0
0 1 2 3 4 5 6 7 8 9 10 11 12
Time in months
Fig. 2. Whole blood and red blood cells. Niacin levels measured over
a period of 12 months in 15 patients on chronic hemodialysis without
vitamin supplementation. The actual values in all of the patients are
shown. The line connects the mean for each value. The area between
the solid lines represents normal values.
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Fig. 1. Red blood cells and plasma folate levels measured over a
period of 12 months in 15 patients on chronic hemodialysis without
vitamin supplementation. The actual values in all of the patients are
shown. The line connects the mean for each value. The area between
the solid lines represents normal values.
Table 2 shows the vitamin C levels of plasma in seventeen
patients, prior to hemodialysis procedures, two hr into the
dialysis, and following dialysis. Vitamin C supplement was
withdrawn from all of these patients for at least four months
previously. Vitamin C levels in all cases remained in the normal
and comparable range during all three stages of dialysis. The
blood ascorbic acid levels in hemodialysis patients and normal
controls are compared in Table 3. Significant differences were
found in the vitamin C levels between the control group and the
patients after withdrawal of vitamin C. Although the levels of
vitamin C were low in comparison with controls, they were
within the normal range.
In Table 4, the yearly hematologic values and laboratory
values of some nutritional indices for the fifteen patients that
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Fig. 5. Blood ascorbic acid levels measured over a period of 12 months
in 15 patients on chronic hemodialysis without vitamin supplementa-
tion. The actual values in all of the patients are shown. The line
connects the mean for each patient. The area between the solid lines
represents normal values.
Table 2. Changes in ascorbic acid levels in blood due to hemodialysis
procedure.
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Fig. 3. Plasma B6 and B,2 levels measured over a period of 12 months
in 15 patients on chronic hemodialysis without vitamin supplementa-
tion. The actual values in all of the patients are shown. The line
connects the mean for each value. The area between the solid lines
represents normal values.
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Fig. 4. Plasma and red cell thiamine levels measured over a period of
12 months in 15 patients on chronic hemodialysis without vitamin
supplementation. The actual values in all of the patients are shown. The
line connects the mean for each value. The area between the solid lines
represents normal values.
.Patient
number
Ascorbic acid levels in blood collected, pg/mi
Pre-dialysis During dialysis Post-dialysis
I 11.47 7.1 9.1
2* 6.27
6.3
3.9
7.9
9.2
7.5
3 6.3 7.9 7.5
4 4.9 3.3 3.5
5 6.0 5.1 4.9
6 10.0 9.1 9.9
7* 7.1
8.9
4.9
10.3
10.3
5.9
8 5.9 5,6 4.0
9 12.9 10.7 6.3
10 7.3 6.9 7.9
11 8.3 8.3 4.8
12* 12.8
21.1
22.7
21.1
12.8
17.3
13* 7.2
7.1
3.9
5.2
17.5
6.1
14 16.7 11.3 16.3
15 10.9 10.8 6.0
16 10.4 7.2 6.3
17 7.2 11.3 9.7
Mean SD (N = 21) 9.29 4.0 8.64 5.1" 8.58 4.24c
Differences between a vs. b, b vs. c, c vs. a, not significant (1-test, P
values > 0.05).
* Patients tested twice, one week apart.
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Table 3. Comparison between blood ascorbic acid levels in hemodialysis patients and normal controls.
Ascorbic
acid
gIml
Group Age Number mean SD Statistical significance
Controls
(a) Young adult* normal 34 13 8 16.64 3.6 (a) vs. (b)
P> 0.01
(Not significant)
(b) Aged* 72 10 12 14.78 2.6
Patients
(c) Prior to vitamin C withdrawal 34 11 10 27.1 11.1 (a) or (b) vs. (c)-P < 0.01
(Highly significant)
(d) One year after vitamin C withdrawal 44 11 8 7.8 2.24 (a) or (b) vs. (d)-P < 0.01
(Highly significant)
* Volunteers on normal diet but without supplement.
Table 4. Hematologic values and laboratory values of some nutritional induces in 15 patients on chronic hemodialysis at the beginning of the
study and at the end (mean SD).
Test Control 12 Months Test Control 12 Months
Hemoglobin 13—17 gidI
Hematocrit %
10.6 2.1
34 7.3
11.2 2.4
35.4 7.7
WBC 5—100 X
Total lymphocytes
6.1 1.4
1000 376
5.8 1.9
1119.9 380.3
MCV 82—96 p
MCH 28—32 pg
MCHC 32—36%
86.6 9.7
28.3 3.5
31.9 2.4
88.9 9.7
28.4 3.7
31.8 1.1
Total proteins 6—8.5 gIdi
Albumin 3—5.5 gIdi
Transferrin mgldl
6.8 0.5
3.7 0.2
6.8 0.8
3.6 0.5
176.0 3.7
Platelets 140—44 x 10 214.5 56 204.5 10.32 Cholesterol 150—330 mg/dl 184.3 47 229.6 48.4
Iron 50—150 p.gIdl
Iron binding capacity 250—
57.6 20.6
257.1 42.3
100.5 63.7
285.8 67.4
Triglycerides 30—135 mgldl
Glucose 70—125 mgldl
184 101
125.6 38.8
161.6 91.8
148.1 43.2
450 pgIdl
Weight (kg) 73 6.8 70.9 S
participated in the study are shown. No changes in blood values
were encountered throughout the study, including the hemato-
logic indices. For simplicity, only the control values and the
values at the end of the study are displayed.
Table 5 shows several of the serum enzymes that can be
abnormal if vitamin deficiency anemias are present or if liver or
muscle damage is induced. The CPK and SGOT were normal
and did not change throughout the period of observation.
However, the LDH and alkaline phosphatase were slightly
elevated in the control period and increased slightly during the
period of vitamin deprivation. This increment was not signifi-
cant (P > 0.05).
Discussion
The inclusion of the B vitamins in the daily supplementation
of the hemodialysis patients was due to the belief that these
vitamins were easily removed during dialysis because of their
small molecular sizes (except vitamin B12). Furthermore, it
could be assumed that the intake of the vitamins may be
inadequate, or their metabolism may be altered by the admin-
istration of certain drugs [22—26]. The purpose of this investi-
gation was to determine the need for daily supplements of the
water soluble vitamins in hemodialysis patients. In this study,
we measured the blood vitamin B12, folate, B6, niacin, thiamine
and vitamin C levels at certain intervals over a period of a year
in a number of hemodialysis patients who did not receive
vitamin supplements. We found that most of the patients were
able to maintain normal vitamin levels over a period of a year
from dietary intake alone. A few, however, were found to have
blood folate, B6, thiamin and niacin levels below the normal
range.
Previously, some studies reported low blood levels for folate,
vitamin B12, B6 and vitamin C in hemodialysis patients unless
these patients received vitamin supplements [1, 27, 28, 30, 31].
Other studies found normal to above normal levels of folate,
vitamin B12, biotin, niacin, pantothenate, thiamin and riboflavin
[10, 19, 29]. The discrepancies in these studies may be due to
the fact that different laboratories used different methods to
assess the vitamin status of uremic patients.
In our study, we chose the microbiological methods for the
measurement of the B complex vitamins because microbiolog-
ical assays have been shown to be the most specific of all
methods available for vitamin B analysis.
Several investigators [18, 20, 32, 33] have shown that the
microorganisms used in the assays respond only to the biolog-
ically active forms of the vitamins and do not respond to
metabolites of the vitamins.
There are only two binder assay systems available for the
measurement of the B vitamins: vitamin B12 and folate. The
binder assay system for vitamin B12 was used for 15 years
before it was reported as unreliable by Koihouse et al [33] and
Cooper and Whitehead [34]. The binder assay had consistently
given higher B12 values [35—43]. As for the binder assay system
for folate, many investigators criticized it as non-specific,
unreliable, and in need of improvement [44—47].
The chemical methods such as the Konig reaction, the
fluorometric densitometric method and the measurement of
methylated metabolites in the urine for the measurement of
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niacin are influenced by biologically inactive materials [48—51]
and cannot be used in our patients.
With these reasons in mind, we found in our study that the
levels of folate that were initially high, rapidly declined after
stopping the supplementation, but only a few patients had folate
values below the normal range. Blood levels of thiamine,
niacin, B6, B12 and vitamin C were in the normal range without
vitamin supplementation, and again, only a few patients had
values below the normal range. These findings may be ex-
plained by the fact that, in vivo, the B vitamins are protein
bound, a fact that was well known with vitamin B12 [1]. Folate
appears to be bound to proteins as well [52—571 and mainly to
albumin [541. In addition, there are high affinity, specific binders
(MW approximately 42,000) that demonstrate saturation kinet-
ics present in the plasma for this vitamin [56,571. Furthermore,
it has been described [56] that the total fotate binding capacity
of the plasma is significantly elevated in uremic patients.
Therefore, folate may not be as freely available to be dialyzed
as has been thought in the past.
Vitamin B6 is a group name and consists of three pyridine
related compounds: pyridoxine, pyridoxal and pyridoxamine.
These may appear in tissues and foodstuffs in the free form, or
combined with phosphate or with phosphate and protein. The
physiological active form of vitamin B6 is the co-enzyme
"pyridoxal phosphate", which can be formed from any of the
three compounds. Some studies [58, 59] have indicated that
these three free forms have identical biological activity in
humans. Thus, an assay for vitamin B6 should be equally
sensitive to each of these free forms [18]. Therefore, the
biochemical diagnosis of vitamin B6 deficiency in man generally
involves the measurement of: 1) decreased quantities of the
vitamin and its related compounds in plasma or blood cells; 2)
decreased urinary excretion of 4-pyridoxic acid, as the main
inactive form of the vitamin; and 3) derangement of metabolism
and enzymatic processes in which the vitamin is known to serve
a crucial function [60—63]. Therefore, it is understandable that
none of the available methods are always useful, and their
strengths and limitations can change in accordance with prob-
lems to which they are applied.
There are 12 different methods available for use in assess-
ment of vitamin B6 status. Of these methods, the "tryptophan
load test", measurement of "plasma pyridoxal-P04" level, and
measurement of "red cell transaminase" activities are consid-
ered the most sensitive and reflective of vitamin B6 status [59,
64]. Therefore, for the best evaluation B5 nutriture, all three
methods should be used. However, in patients with chronic
renal failure, it is not possible to perform the tryptophan load
test and measure (before and after) the urinary excretion of
xanthurenic acid, since excretion is abnormal in these patients
and it is not possible to collect normal 24 hr urine samples.
Measurement of red cell transaminase activities may not be
ideal because in patients with chronic renal failure, red cell
synthesis is abnormal and red cell life span is decreased.
Enzyme activities in red cells depend on the life span of the cell.
Since the tryptophan load test and the measurement of
transaminase activities may be abnormal in patients with
chronic renal failure, the only method left to assess B6 nutriture
is to measure plasma vitamin B6 level. We chose the microbi-
ological assay with "Kloeckera brevis" as the test organism
because it has been shown [16, 65] that this organism is specific
and responds only to the biologically active forms of B6. Also,
we chose to measure total plasma B6 instead of plasma pyri-
doxal-PO4 because pyridoxal, pyridoxine, and pyridoxamine
are biologically active. Also, according to Anderson [66],
pyridoxal phosphate is rapidly converted into pyridoxal in the
red cell which is in equilibrium with plasma. Therefore, the
assay of pyridoxal phosphate is misleading and the measure-
ment of plasma pyridoxal-PO4 underestimated the B6 in plasma.
Our data indicates that the majority of the patients with
chronic renal failure do not appear to be vitamin B6 deficient as
has been suggested in many publications. However, it is possi-
ble that these patients may require higher levels of B6 than the
Recommended Dietary Allowance of 2.2 mg for male and 2.0
for female, for normal enzyme reactions, due to the presence of
inhibitors of vitamin B6 [671.
Nicotinic acid and its derivatives occur in biologic materials
as the free acid, as nicotinamide, and in more or less tightly
bound co-enzyme forms: nicotinamide adenine dinucleotide
(NAD), and nicotinamide adenine dinucleotide phosphate
(NADP). Since this vitamin does not circulate as a free com-
pound, its dialyzability is, therefore, questionable. Thiamine is
carried to the liver and kidneys bound to plasma proteins where
it is phosphorylated to cocarboxylase [211. Extraction of the
thiamine is necessary for the assay of the vitamin indicating its
unavailability for dialysis, a fact again in accordance with our
findings.
In 1970, Sullivan and Eisenstein [68] described ascorbic acid
depletion in patients undergoing long—term hemodialysis, and
demonstrated tissue depletion of this vitamin as well [69]. These
findings were later confirmed by other authors [70]. Although
we did not measure tissue levels of ascorbic acid, the plasma
ascorbate levels were found to be normal in our patients.
Furthermore, we did not find any depletion over a year fol-
low-up study. We cannot explain the difference at the present
time as more study is needed in this area.
In summary, we have shown that at least six vitamins of the
"water soluable group" are not depleted in the majority of the
dialysis patients without supplementation. However, this find-
ing is not by any means conclusive and raises further questions
for research into nutrition, vitamins, assays, vitamin binders,
etc., in the dialysis population. Moreover, the possibility of
unknown interactions between patient medications and the
absorption or metabolism of these vitamins requires further
exploration.
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